Full name
MILFARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.78.Z - Retail sale of other new products
73.20.Z - Market research and public opinion polling
82.99.Z - Other business support activities, not elsewhere classified
86.90.E - Healthcare
96.04.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,7 | 0,8 | 0,3 | -57,8 |
Gross profit (loss) | 1 | 0,8 | 0,4 | -53,4 |
EBITDA | 1,2 | 1 | 0,5 | -49,9 |
Short time liabilities | 2,8 | 4,1 | 6,1 | 48,6 |
Other operating costs | 0,1 | 0 | 0 | 54,5 |
Equity capital | 2,1 | 2,8 | 3 | 10,5 |
Operating profit (EBIT) | 1 | 0,8 | 0,4 | -53,4 |
Assets | 5,2 | 6,9 | 9,2 | 33,1 |
Net profit (loss) | 0,9 | 0,7 | 0,3 | -57 |
Cash | 0,6 | 0,7 | 1 | 45,5 |
Liabilities and provisions for liabilities | 3,1 | 4,2 | 6,2 | 47,9 |
Net income from sale | 26,2 | 33,9 | 38,2 | 12,5 |
Working assets | 4,2 | 5,2 | 6,3 | 22 |
Other income costs | 0,4 | 0 | 0,1 | 7071,3 |
Depreciation | 0,2 | 0,2 | 0,1 | -36,7 |
% | % | % | p.p. | |
Profitability of capital | 43,7 | 24,3 | 9,5 | -14,8 |
Equity capital to total assets | 40,1 | 39,7 | 33 | -6,7 |
Gross profit margin | 3,9 | 2,3 | 0,9 | -1,4 |
EBITDA Margin | 4,6 | 2,9 | 1,3 | -1,6 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 40 | 44 | 58 | 14 |
Current financial liquidity indicator | 1.460261344909668 | 1.2568284273147583 | 1.0320160388946533 | -0,3 |
Net dept to EBITDA | -0.30439990758895874 | -0.6110759377479553 | -2.005011558532715 | -1,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane